TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Gene-based Advanced Therapy Medicinal Market, Global Outlook and Forecast 2023-2030

Gene-based Advanced Therapy Medicinal Market, Global Outlook and Forecast 2023-2030

  • Category:Life Sciences
  • Published on : 25 January 2023
  • Pages :61
  • Formats:
  • Report Code:SMR-7543422
OfferClick for best price

Best Price: $2600

Genebased Advanced Therapy Medicinal Market Size

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
This report contains market size and forecasts of Gene-based Advanced Therapy Medicinal in Global, including the following market information:
Global Gene-based Advanced Therapy Medicinal Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Gene-based Advanced Therapy Medicinal market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Viral Gene Delivery System Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Gene-based Advanced Therapy Medicinal include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene-based Advanced Therapy Medicinal companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene-based Advanced Therapy Medicinal Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Gene-based Advanced Therapy Medicinal Market Segment Percentages, by Type, 2022 (%)
Viral Gene Delivery System
Non-viral Gene Delivery System
Global Gene-based Advanced Therapy Medicinal Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Gene-based Advanced Therapy Medicinal Market Segment Percentages, by Application, 2022 (%)
Neurological Diseases
Cancer
Other
Global Gene-based Advanced Therapy Medicinal Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Gene-based Advanced Therapy Medicinal Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene-based Advanced Therapy Medicinal revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene-based Advanced Therapy Medicinal revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Gene-based Advanced Therapy Medicinal Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene-based Advanced Therapy Medicinal Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene-based Advanced Therapy Medicinal Overall Market Size
2.1 Global Gene-based Advanced Therapy Medicinal Market Size: 2022 VS 2030
2.2 Global Gene-based Advanced Therapy Medicinal Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene-based Advanced Therapy Medicinal Players in Global Market
3.2 Top Global Gene-based Advanced Therapy Medicinal Companies Ranked by Revenue
3.3 Global Gene-based Advanced Therapy Medicinal Revenue by Companies
3.4 Top 3 and Top 5 Gene-based Advanced Therapy Medicinal Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene-based Advanced Therapy Medicinal Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene-based Advanced Therapy Medicinal Players in Global Market
3.6.1 List of Global Tier 1 Gene-based Advanced Therapy Medicinal Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene-based Advanced Therapy Medicinal Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Gene-based Advanced Therapy Medicinal Market Size Markets, 2022 & 2030
4.1.2 Viral Gene Delivery System
4.1.3 Non-viral Gene Delivery System
4.2 By Type - Global Gene-based Advanced Therapy Medicinal Revenue & Forecasts
4.2.1 By Type - Global Gene-based Advanced Therapy Medicinal Revenue, 2018-2023
4.2.2 By Type - Global Gene-based Advanced Therapy Medicinal Revenue, 2023-2030
4.2.3 By Type - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene-based Advanced Therapy Medicinal Market Size, 2022 & 2030
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 Other
5.2 By Application - Global Gene-based Advanced Therapy Medicinal Revenue & Forecasts
5.2.1 By Application - Global Gene-based Advanced Therapy Medicinal Revenue, 2018-2023
5.2.2 By Application - Global Gene-based Advanced Therapy Medicinal Revenue, 2023-2030
5.2.3 By Application - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Gene-based Advanced Therapy Medicinal Market Size, 2022 & 2030
6.2 By Region - Global Gene-based Advanced Therapy Medicinal Revenue & Forecasts
6.2.1 By Region - Global Gene-based Advanced Therapy Medicinal Revenue, 2018-2023
6.2.2 By Region - Global Gene-based Advanced Therapy Medicinal Revenue, 2023-2030
6.2.3 By Region - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Gene-based Advanced Therapy Medicinal Revenue, 2018-2030
6.3.2 US Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.3.3 Canada Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.3.4 Mexico Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Gene-based Advanced Therapy Medicinal Revenue, 2018-2030
6.4.2 Germany Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.3 France Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.4 U.K. Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.5 Italy Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.6 Russia Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.7 Nordic Countries Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.4.8 Benelux Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Gene-based Advanced Therapy Medicinal Revenue, 2018-2030
6.5.2 China Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.5.3 Japan Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.5.4 South Korea Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.5.5 Southeast Asia Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.5.6 India Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Gene-based Advanced Therapy Medicinal Revenue, 2018-2030
6.6.2 Brazil Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.6.3 Argentina Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue, 2018-2030
6.7.2 Turkey Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.7.3 Israel Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.7.4 Saudi Arabia Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
6.7.5 UAE Gene-based Advanced Therapy Medicinal Market Size, 2018-2030
7 Players Profiles
7.1 Biogen
7.1.1 Biogen Corporate Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene-based Advanced Therapy Medicinal Major Product Offerings
7.1.4 Biogen Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.1.5 Biogen Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene-based Advanced Therapy Medicinal Major Product Offerings
7.2.4 Novartis Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News
7.3 Gilead Sciences
7.3.1 Gilead Sciences Corporate Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Major Product Offerings
7.3.4 Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.3.5 Gilead Sciences Key News
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Corporate Summary
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.4.4 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.4.5 Sarepta Therapeutics Key News
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Corporate Summary
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Major Product Offerings
7.5.4 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.5.5 Alnylam Pharmaceuticals Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene-based Advanced Therapy Medicinal Major Product Offerings
7.6.4 Amgen Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Corporate Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.7.4 Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.7.5 Spark Therapeutics Key News
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Corporate Summary
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.8.4 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.8.5 Akcea Therapeutics Key News
7.9 Sunway Biotech
7.9.1 Sunway Biotech Corporate Summary
7.9.2 Sunway Biotech Business Overview
7.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Major Product Offerings
7.9.4 Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.9.5 Sunway Biotech Key News
7.10 SIBIONO
7.10.1 SIBIONO Corporate Summary
7.10.2 SIBIONO Business Overview
7.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Major Product Offerings
7.10.4 SIBIONO Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.10.5 SIBIONO Key News
7.11 AnGes
7.11.1 AnGes Corporate Summary
7.11.2 AnGes Business Overview
7.11.3 AnGes Gene-based Advanced Therapy Medicinal Major Product Offerings
7.11.4 AnGes Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.11.5 AnGes Key News
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Corporate Summary
7.12.2 Orchard Therapeutics Business Overview
7.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Major Product Offerings
7.12.4 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.12.5 Orchard Therapeutics Key News
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Corporate Summary
7.13.2 Human Stem Cells Institute Business Overview
7.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Major Product Offerings
7.13.4 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue in Global Market (2018-2023)
7.13.5 Human Stem Cells Institute Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Gene-based Advanced Therapy Medicinal Market Opportunities & Trends in Global Market
Table 2. Gene-based Advanced Therapy Medicinal Market Drivers in Global Market
Table 3. Gene-based Advanced Therapy Medicinal Market Restraints in Global Market
Table 4. Key Players of Gene-based Advanced Therapy Medicinal in Global Market
Table 5. Top Gene-based Advanced Therapy Medicinal Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene-based Advanced Therapy Medicinal Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene-based Advanced Therapy Medicinal Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene-based Advanced Therapy Medicinal Product Type
Table 9. List of Global Tier 1 Gene-based Advanced Therapy Medicinal Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene-based Advanced Therapy Medicinal Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Gene-based Advanced Therapy Medicinal Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene-based Advanced Therapy Medicinal Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Gene-based Advanced Therapy Medicinal Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene-based Advanced Therapy Medicinal Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2023-2030
Table 30. Biogen Corporate Summary
Table 31. Biogen Gene-based Advanced Therapy Medicinal Product Offerings
Table 32. Biogen Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 33. Novartis Corporate Summary
Table 34. Novartis Gene-based Advanced Therapy Medicinal Product Offerings
Table 35. Novartis Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 36. Gilead Sciences Corporate Summary
Table 37. Gilead Sciences Gene-based Advanced Therapy Medicinal Product Offerings
Table 38. Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 39. Sarepta Therapeutics Corporate Summary
Table 40. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product Offerings
Table 41. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 42. Alnylam Pharmaceuticals Corporate Summary
Table 43. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product Offerings
Table 44. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 45. Amgen Corporate Summary
Table 46. Amgen Gene-based Advanced Therapy Medicinal Product Offerings
Table 47. Amgen Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 48. Spark Therapeutics Corporate Summary
Table 49. Spark Therapeutics Gene-based Advanced Therapy Medicinal Product Offerings
Table 50. Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 51. Akcea Therapeutics Corporate Summary
Table 52. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product Offerings
Table 53. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 54. Sunway Biotech Corporate Summary
Table 55. Sunway Biotech Gene-based Advanced Therapy Medicinal Product Offerings
Table 56. Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 57. SIBIONO Corporate Summary
Table 58. SIBIONO Gene-based Advanced Therapy Medicinal Product Offerings
Table 59. SIBIONO Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 60. AnGes Corporate Summary
Table 61. AnGes Gene-based Advanced Therapy Medicinal Product Offerings
Table 62. AnGes Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 63. Orchard Therapeutics Corporate Summary
Table 64. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product Offerings
Table 65. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
Table 66. Human Stem Cells Institute Corporate Summary
Table 67. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product Offerings
Table 68. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Gene-based Advanced Therapy Medicinal Segment by Type in 2022
Figure 2. Gene-based Advanced Therapy Medicinal Segment by Application in 2022
Figure 3. Global Gene-based Advanced Therapy Medicinal Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene-based Advanced Therapy Medicinal Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Gene-based Advanced Therapy Medicinal Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene-based Advanced Therapy Medicinal Revenue in 2022
Figure 8. By Type - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
Figure 9. By Application - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
Figure 10. By Region - Global Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
Figure 11. By Country - North America Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
Figure 12. US Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
Figure 16. Germany Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 17. France Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
Figure 24. China Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 28. India Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
Figure 30. Brazil Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue Market Share, 2018-2030
Figure 33. Turkey Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Gene-based Advanced Therapy Medicinal Revenue, (US$, Mn), 2018-2030
Figure 37. Biogen Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Novartis Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. SIBIONO Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AnGes Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount